Geron Corporation has grown revenue −2.2% a year over three years and −26% a year over five. Revenue growth, 3-year annual rate: −2.2% (Biotechnology median +17%). Revenue growth, 5-year rate: −26%, growth has picked up over the last three years. Years of annual history on file: 17, FY2009 to FY2025, as filed.

GERNGeron Corporation

Healthcare

$1.21-6.2% 1Y

$1.21

$1.0752 weeks$1.95

Is it growing?

Is GERN growing?

Geron Corporation has grown revenue −2.2% a year over three years and −26% a year over five.

−2.2%

Revenue growth, 3-year annual rate · Biotechnology median +17% · shrinking · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: −26%
Revenue growth, 5-year rate · −2.2% over three · growth has picked up over the last three years
Years of annual history on file: 17
Years of annual history on file · FY2009 to FY2025, as filed

Details›